After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ELVN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Enliven Therapeutics Inc is $1.53B. A total of 0.71 million shares were traded on the day, compared to an average of 964.27K shares.
In the most recent transaction, Lyssikatos Joseph P sold 20,000 shares of ELVN for 26.75 per share on Jan 20 ’26. After the transaction, the CHIEF SCIENTIFIC OFFICER now owns 745,188 company shares. In a previous transaction on Jan 20 ’26, Heyman Richard A. sold 1,230 shares at 26.75 per share. ELVN shares that Director owns now total 23,877.
Among the insiders who bought shares, Heyman Richard A. acquired of 1,230 shares on Jan 20 ’26 at a per-share price of $26.71. In another insider transaction, Patel Anish sold 48,300 shares at $27.99 per share on Jan 09 ’26. Company shares held by the CHIEF OPERATING OFFICER now total 215,011.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ELVN has a high of $29.98 and a low of $13.30.
As of this writing, ELVN has an earnings estimate of -$0.47 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.45 per share and a lower estimate of -$0.5. The company reported an EPS of -$0.46 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ELVN’s latest balance sheet shows that the firm has $110.02M in Cash & Short Term Investments as of fiscal 2021. There were $159.00k in debt and $5.75M in liabilities at the time. Its Book Value Per Share was $8.03, while its Total Shareholder’s Equity was -$42.89M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
